Seminars in Pediatric Surgery
Volume 16, Issue 2 , Pages 80-87 , May 2007

Pulmonary vascular remodeling

  • Doug Miniati, MD

      Affiliations

    • Corresponding Author InformationAddress reprint requests and correspondence: Doug Miniati, MD, UCSF Division of Pediatric Surgery, 513 Parnassus Avenue, HSW-1601, Box 0570, San Francisco, CA 94143-0570.

References 

  1. Chiu PP, Sauer C, Mihailovic A, et al. The price of success in the management of congenital diaphragmatic hernia: is improved survival accompanied by an increase in long-term morbidity?. J Pediatr Surg. 2006;41:888–892
  2. Crankson SJ, Al Jadaan SA, Namshan MA. The immediate and long-term outcomes of newborns with congenital diaphragmatic hernia. Pediatr Surg Int. 2006;22:335–340
  3. Cortes RA, Keller RL, Townsend T, et al. Survival of severe congenital diaphragmatic hernia has morbid consequences. J Pediatr Surg. 2005;40:36–45, discussion 45-6.
  4. Javid PJ, Jaksic T, Skarsgard ED, et al. Survival rate in congenital diaphragmatic hernia: the experience of the Canadian Neonatal Network. J Pediatr Surg. 2004;39:657–660
  5. Trachsel D, Selvadurai H, Bohn D, et al. Long-term pulmonary morbidity in survivors of congenital diaphragmatic hernia. Pediatr Pulmonol. 2005;39:433–439
  6. Therese P. Persistent pulmonary hypertension of the newborn. Paediatr Respir Rev. 2006;7:S175–S176
  7. Jeffery TK, Morrell NW. Molecular and cellular basis of pulmonary vascular remodeling in pulmonary hypertension. Prog Cardiovasc Dis. 2002;45:173–202
  8. Stenmark KR, Gebb SA. Lung vascular development: breathing new life into an old problem. Am J Respir Cell Mol Biol. 2003;28:133–137
  9. deMello DE, Reid LM. Embryonic and early fetal development of human lung vasculature and its functional implications. Pediatr Dev Pathol. 2000;3:439–449
  10. Hall SM, Hislop AA, Pierce CM, et al. Prenatal origins of human intrapulmonary arteries: formation and smooth muscle maturation. Am J Respir Cell Mol Biol. 2000;23:194–203
  11. Schachtner SK, Wang Y, Scott Baldwin H. Qualitative and quantitative analysis of embryonic pulmonary vessel formation. Am J Respir Cell Mol Biol. 2000;22:157–165
  12. Mitzner W, Wagner EM. Vascular remodeling in the circulations of the lung. J Appl Physiol. 2004;97:1999–2004
  13. Wagenvoort C, Neufeld H, Edwards J. The structure of the pulmonary arterial tree in fetal and early postnatal life. Lab Invest. 1961;10:751–762
  14. Wagenvoort C, Mooi W. The normal lung vessels. In:  Wagenvoort C,  Mooi W editor. Biopsy Pathology of the Pulmonary Vasculature. London: Chapman and Hill Medical; 1989;p. 24–50
  15. Haworth SG. Pulmonary vascular remodeling in neonatal pulmonary hypertension (State of the art). Chest. 1988;93:133S–138S, 1988.
  16. Allen K, Haworth SG. Human postnatal pulmonary arterial remodeling (Ultrastructural studies of smooth muscle cell and connective tissue maturation). Lab Invest. 1988;59:702–709
  17. Burri PH, Hlushchuk R, Djonov V. Intussusceptive angiogenesis: its emergence, its characteristics, and its significance. Dev Dyn. 2004;231:474–488
  18. Pauling MH, Vu TH. Mechanisms and regulation of lung vascular development. Curr Top Dev Biol. 2004;64:73–99
  19. Jeffery TK, Wanstall JC. Pulmonary vascular remodeling: a target for therapeutic intervention in pulmonary hypertension. Pharmacol Ther. 2001;92:1–20
  20. Mandegar M, Fung YC, Huang W, et al. Cellular and molecular mechanisms of pulmonary vascular remodeling: role in the development of pulmonary hypertension. Microvasc Res. 2004;68:75–103
  21. Schwarz M, Lee M, Zhang F, et al. EMAP II: a modulator of neovascularization in the developing lung. Am J Physiol. 1999;276:L365–L375
  22. Chang H, Brown CW, Matzuk MM. Genetic analysis of the mammalian transforming growth factor-beta superfamily. Endocr Rev. 2002;23:787–823
  23. Karner C, Wharton KA, Carroll TJ. Apical-basal polarity, Wnt signaling and vertebrate organogenesis. Semin Cell Dev Biol. 2006;17:214–222
  24. Pongracz JE, Stockley RA. Wnt signalling in lung development and diseases. Respir Res. 2006;7:15
  25. Shu W, Jiang YQ, Lu MM, et al. Wnt7b regulates mesenchymal proliferation and vascular development in the lung. Development. 2002;129:4831–4842
  26. Carlsson P, Mahlapuu M. Forkhead transcription factors: key players in development and metabolism. Dev Biol. 2002;250:1–23
  27. Kim IM, Ramakrishna S, Gusarova GA, et al. The forkhead box m1 transcription factor is essential for embryonic development of pulmonary vasculature. J Biol Chem. 2005;280:22278–22286
  28. Han RN, Post M, Tanswell AK, et al. Insulin-like growth factor-I receptor-mediated vasculogenesis/angiogenesis in human lung development. Am J Respir Cell Mol Biol. 2003;28:159–169
  29. Retsch-Bogart GZ, Moats-Staats BM, Howard K, et al. Cellular localization of messenger RNAs for insulin-like growth factors (IGFs), their receptors and binding proteins during fetal rat lung development. Am J Respir Cell Mol Biol. 1996;14:61–69
  30. Shawber CJ, Kitajewski J. Notch function in the vasculature: insights from zebrafish, mouse and man. Bioessays. 2004;26:225–234
  31. Cheng N, Brantley DM, Chen J. The ephrins and Eph receptors in angiogenesis. Cytokine Growth Factor Rev. 2002;13:75–85
  32. Hall SM, Hislop AA, Haworth SG. Origin, differentiation, and maturation of human pulmonary veins. Am J Respir Cell Mol Biol. 2002;26:333–340
  33. Eklund L, Olsen BR. Tie receptors and their angiopoietin ligands are context-dependent regulators of vascular remodeling. Exp Cell Res. 2006;312:630–641
  34. Dewachter L, Adnot S, Fadel E, et al. Angiopoietin/Tie2 pathway influences smooth muscle hyperplasia in idiopathic pulmonary hypertension. Am J Respir Crit Care Med. 2006;17:17
  35. Colen KL, Crisera CA, Rose MI, et al. Vascular development in the mouse embryonic pancreas and lung. J Pediatr Surg. 1999;34:781–785
  36. Gebb SA, Shannon JM. Tissue interactions mediate early events in pulmonary vasculogenesis. Dev Dyn. 2000;217:159–169
  37. Ruano R, Aubry MC, Barthe B, et al. Quantitative analysis of fetal pulmonary vasculature by 3-dimensional power Doppler ultrasonography in isolated congenital diaphragmatic hernia. Am J Obstet Gynecol. 2006;9:9
  38. Keller RL, Moore P, Teitel D, et al. Abnormal vascular tone in infants and children with lung hypoplasia: findings from cardiac catheterization and the response to chronic therapy. Pediatr Crit Care Med. 2006;26:26
  39. Wohl ME, Griscom NT, Strieder DJ, et al. The lung following repair of congenital diaphragmatic hernia. J Pediatr. 1977;90:405–414
  40. Taira Y, Yamataka T, Miyazaki E, et al. Comparison of the pulmonary vasculature in newborns and stillborns with congenital diaphragmatic hernia. Pediatr Surg Int. 1998;14:30–35
  41. Shehata SM, Sharma HS, van der Staak FH. Remodeling of pulmonary arteries in human congenital diaphragmatic hernia with or without extracorporeal membrane oxygenation. J Pediatr Surg. 2000;35:208–215
  42. Barghorn A, Koslowski M, Kromminga R, et al. Alpha-smooth muscle actin distribution in the pulmonary vasculature comparing hypoplastic and normal fetal lungs. Pediatr Pathol Lab Med. 1998;18:5–22
  43. Levin DL. Morphologic analysis of the pulmonary vascular bed in congenital left-sided diaphragmatic hernia. J Pediatr. 1978;92:805–809
  44. de Rooij JD, Hosgor M, Ijzendoorn Y, et al. Expression of angiogenesis-related factors in lungs of patients with congenital diaphragmatic hernia and pulmonary hypoplasia of other causes. Pediatr Dev Pathol. 2004;7:468–477
  45. Shehata SM, Sharma HS, Mooi WJ, et al. Pulmonary hypertension in human newborns with congenital diaphragmatic hernia is associated with decreased vascular expression of nitric-oxide synthase. Cell Biochem Biophys. 2006;44:147–155
  46. Yamataka T, Puri P. Active collagen synthesis by pulmonary arteries in pulmonary hypertension complicated by congenital diaphragmatic hernia. J Pediatr Surg. 1997;32:682–687
  47. de Lagausie P, de Buys-Roessingh A, Ferkdadji L. Endothelin receptor expression in human lungs of newborns with congenital diaphragmatic hernia. J Pathol. 2005;205:112–118
  48. Okazaki T, Sharma HS, McCune SK, et al. Pulmonary vascular balance in congenital diaphragmatic hernia: enhanced endothelin-1 gene expression as a possible cause of pulmonary vasoconstriction. J Pediatr Surg. 1998;33:81–84
  49. Shinkai T, Shima H, Solari V, et al. Expression of vasoactive mediators during mechanical ventilation in nitrofen-induced diaphragmatic hernia in rats. Pediatr Surg Int. 2005;21:143–147
  50. Oue T, Yoneda A, Shima H, et al. Increased vascular endothelial growth factor peptide and gene expression in hypoplastic lung in nitrofen induced congenital diaphragmatic hernia in rats. Pediatr Surg Int. 2002;18:221–226
  51. Stenmark KR, Mecham RP. Cellular and molecular mechanisms of pulmonary vascular remodeling. Annu Rev Physiol. 1997;59:89–144
  52. Humbert M, Morrell NW, Archer SL, et al. Cellular and molecular pathobiology of pulmonary arterial hypertension. J Am Coll Cardiol. 2004;43:13S–24S
  53. Mohensi-Bod , Bohn D. Pulmonary hypertension in congenital diaphragmatic hernia. Semin Pediatr Surg. 2007;16:126–133
  54. Bratu I, Flageole H, Laberge JM, et al. Pulmonary structural maturation and pulmonary artery remodeling after reversible fetal ovine tracheal occlusion in diaphragmatic hernia. J Pediatr Surg. 2001;36:739–744
  55. Kanai M, Kitano Y, von Allmen D, et al. Fetal tracheal occlusion in the rat model of nitrofen-induced congenital diaphragmatic hernia: tracheal occlusion reverses the arterial structural abnormality. J Pediatr Surg. 2001;36:839–845
  56. Luks FI, Wild YK, Piasecki GJ, et al. Short-term tracheal occlusion corrects pulmonary vascular anomalies in the fetal lamb with diaphragmatic hernia. Surgery. 2000;128:266–272
  57. Roubliova XI, Verbeken EK, Wu J, et al. Effect of tracheal occlusion on peripheric pulmonary vessel muscularization in a fetal rabbit model for congenital diaphragmatic hernia. Am J Obstet Gynecol. 2004;191:830–836
  58. Sylvester KG, Rasanen J, Kitano Y, et al. Tracheal occlusion reverses the high impedance to flow in the fetal pulmonary circulation and normalizes its physiological response to oxygen at full term. J Pediatr Surg. 1998;33:1071–1074, discussion 1074-5.
  59. Heerema AE, Rabban JT, Sydorak RM, et al. Lung pathology in patients with congenital diaphragmatic hernia treated with fetal surgical intervention, including tracheal occlusion. Pediatr Dev Pathol. 2003;6:536–546
  60. Hara A, Chapin CJ, Ertsey R, et al. Changes in fetal lung distension alter expression of vascular endothelial growth factor and its isoforms in developing rat lung. Pediatr Res. 2005;58:30–37
  61. Wallace MJ, Thiel AM, Lines AM, et al. Role of platelet-derived growth factor-B, vascular endothelial growth factor, insulin-like growth factor-II, mitogen-activated protein kinase and transforming growth factor-beta1 in expansion-induced lung growth in fetal sheep. Reprod Fertil Dev. 2006;18:655–665
  62. Cloutier M, Seaborn T, Piedboeuf B, et al. Effect of temporary tracheal occlusion on the endothelin system in experimental cases of diaphragmatic hernia. Exp Lung Res. 2005;31:391–404
  63. Taira Y, Miyazaki E, Ohshiro K, et al. Administration of antenatal glucocorticoids prevents pulmonary artery structural changes in nitrofen-induced congenital diaphragmatic hernia in rats. J Pediatr Surg. 1998;33:1052–1056
  64. Taira Y, Shima H, Miyazaki E, et al. Antenatal dexamethasone administration inhibits smooth-muscle-cell DNA synthesis in pulmonary-arterial media in nitrofen-induced congenital diaphragmatic hernia in rats. Pediatr Surg Int. 2000;16:414–416
  65. Shima H, Oue T, Taira Y, et al. Antenatal dexamethasone enhances endothelin receptorB expression in hypoplastic lung in nitrofen-induced diaphragmatic hernia in rats. J Pediatr Surg. 2000;35:203–207
  66. Hoeper MM. Drug treatment of pulmonary arterial hypertension: current and future agents. Drugs. 2005;65:1337–1354
  67. Berman Rosenzweig E, Barst RJ. Pulmonary arterial hypertension: a comprehensive review of pharmacological treatment. Treat Respir Med. 2006;5:117–127
  68. Beghetti M. Current treatment options in children with pulmonary arterial hypertension and experiences with oral bosentan. Eur J Clin Invest. 2006;36:16–24

PII: S1055-8586(07)00003-0

doi: 10.1053/j.sempedsurg.2007.01.002

Seminars in Pediatric Surgery
Volume 16, Issue 2 , Pages 80-87 , May 2007

Article Tools